S&P 500   3,852.36
DOW   32,920.46
QQQ   311.72
Retirement Plans in 2023: Choosing the Right Account
Know Your Profit Potential BEFORE You Trade! (Ad)pixel
Mullen Automotive Stock Gains Momentum On Positive News
Apple’s Earnings, Expectations and Surprises
Know Your Profit Potential BEFORE You Trade! (Ad)pixel
Cathie Woods' Ark Innovation ETF Set To Rebound in 2023?
The Bottom Is In For Meta Platforms, Volatility Is Not Over
Cash Holders STILL Aren't Taking Steps to Prepare (Ad)
Exxon Mobil Could Gush To New Highs Very Soon 
Closing prices for crude oil, gold and other commodities
S&P 500   3,852.36
DOW   32,920.46
QQQ   311.72
Retirement Plans in 2023: Choosing the Right Account
Know Your Profit Potential BEFORE You Trade! (Ad)pixel
Mullen Automotive Stock Gains Momentum On Positive News
Apple’s Earnings, Expectations and Surprises
Know Your Profit Potential BEFORE You Trade! (Ad)pixel
Cathie Woods' Ark Innovation ETF Set To Rebound in 2023?
The Bottom Is In For Meta Platforms, Volatility Is Not Over
Cash Holders STILL Aren't Taking Steps to Prepare (Ad)
Exxon Mobil Could Gush To New Highs Very Soon 
Closing prices for crude oil, gold and other commodities
S&P 500   3,852.36
DOW   32,920.46
QQQ   311.72
Retirement Plans in 2023: Choosing the Right Account
Know Your Profit Potential BEFORE You Trade! (Ad)pixel
Mullen Automotive Stock Gains Momentum On Positive News
Apple’s Earnings, Expectations and Surprises
Know Your Profit Potential BEFORE You Trade! (Ad)pixel
Cathie Woods' Ark Innovation ETF Set To Rebound in 2023?
The Bottom Is In For Meta Platforms, Volatility Is Not Over
Cash Holders STILL Aren't Taking Steps to Prepare (Ad)
Exxon Mobil Could Gush To New Highs Very Soon 
Closing prices for crude oil, gold and other commodities
S&P 500   3,852.36
DOW   32,920.46
QQQ   311.72
Retirement Plans in 2023: Choosing the Right Account
Know Your Profit Potential BEFORE You Trade! (Ad)pixel
Mullen Automotive Stock Gains Momentum On Positive News
Apple’s Earnings, Expectations and Surprises
Know Your Profit Potential BEFORE You Trade! (Ad)pixel
Cathie Woods' Ark Innovation ETF Set To Rebound in 2023?
The Bottom Is In For Meta Platforms, Volatility Is Not Over
Cash Holders STILL Aren't Taking Steps to Prepare (Ad)
Exxon Mobil Could Gush To New Highs Very Soon 
Closing prices for crude oil, gold and other commodities
NASDAQ:GLPG

Galapagos - GLPG Stock Forecast, Price & News

$43.40
-0.27 (-0.62%)
(As of 02/2/2023 12:00 AM ET)
Add
Compare
Today's Range
$43.05
$44.07
50-Day Range
$37.44
$48.00
52-Week Range
$37.24
$72.11
Volume
111,414 shs
Average Volume
105,719 shs
Market Capitalization
$2.86 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$52.46

Galapagos MarketRank™ Forecast

Analyst Rating
Hold
2.00 Rating Score
Upside/​Downside
20.9% Upside
$52.46 Price Target
Short Interest
Healthy
1.53% of Shares Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
N/A
Insider Trading
N/A
Proj. Earnings Growth
Decreasing
From ($1.84) to ($3.25) Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.72 out of 5 stars

Medical Sector

841st out of 1,030 stocks

Pharmaceutical Preparations Industry

417th out of 502 stocks

GLPG stock logo

About Galapagos (NASDAQ:GLPG) Stock

Galapagos NV is a biotechnology company, which engages in the identification and development of small molecule and antibody therapies. Its clinical pipeline includes filgotinib, GLP3667, Toledo program, and idiopathic pulmonary fibrosis. The company was founded by Onno van de Stolpe, Rudi Pauwels, and Helmuth van Es on June 30, 1999 and is headquartered in Mechelen, Belgium.

Receive GLPG Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Galapagos and its competitors with MarketBeat's FREE daily newsletter.

GLPG Stock News Headlines

Galapagos (NASDAQ:GLPG) Shares Gap Up to $45.82
Cash Holders STILL Aren't Taking Steps to Prepare
Stocks are crashing... inflation is through the roof... multiple industries are getting hit hard... Americans are fearful of what might happen to their stock portfolios right now -- and who's to blame them? But former Wall Street money manager Louis Navellier says all it takes is being on the right side of this force driving the massive divide. Take action today and watch his exclusive presentation -- absolutely free of charge -- to see how you should be prepping for this phenomenon.
3 Beaten-Down Drug Stocks Poised for a Turnaround in 2023
Galapagos announces changes to Executive Committee
Know Your Profit Potential BEFORE You Trade!
I’m Chuck Hughes, ten-time trading champion and author of the coveted e-book, “Options Trading Made Easy”, the strategy guide that will teach you to calculate your trade’s profit potential before you risk any capital. Click here for a free copy now! pixel
Galapagos NV (GLPG.AS)
Galapagos N.V. ADR
Expert Ratings for Galapagos
See More Headlines
Receive GLPG Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Galapagos and its competitors with MarketBeat's FREE daily newsletter.

GLPG Company Calendar

Today
2/02/2023
Next Earnings (Estimated)
2/23/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Pharmaceutical preparations
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:GLPG
Employees
1,309
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$52.46
High Stock Price Forecast
$70.00
Low Stock Price Forecast
$40.00
Forecasted Upside/Downside
+20.9%
Consensus Rating
Hold
Rating Score (0-4)
2.00
Research Coverage
7 Analysts

Profitability

Net Income
$-122,130,000.00
Pretax Margin
2.34%

Debt

Sales & Book Value

Annual Sales
$573.66 million
Book Value
$47.71 per share

Miscellaneous

Free Float
63,920,000
Market Cap
$2.86 billion
Optionable
Optionable
Beta
0.31

Key Executives

  • Paulus Stoffels
    Chairman & Chief Executive Officer
  • Bart Filius
    President, Chief Operating & Financial Officer
  • Michele Manto
    Chief Commercial Officer
  • Phil Dudfield
    Managing Director-Fidelta
  • Sandra Cauwenberghs
    Director-Investor Relations













GLPG Stock - Frequently Asked Questions

Should I buy or sell Galapagos stock right now?

7 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Galapagos in the last twelve months. There are currently 7 hold ratings for the stock. The consensus among Wall Street analysts is that investors should "hold" GLPG shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in GLPG, but not buy additional shares or sell existing shares.
View GLPG analyst ratings
or view top-rated stocks.

What is Galapagos' stock price forecast for 2023?

7 Wall Street research analysts have issued 12 month price targets for Galapagos' stock. Their GLPG share price forecasts range from $40.00 to $70.00. On average, they expect the company's stock price to reach $52.46 in the next twelve months. This suggests a possible upside of 21.1% from the stock's current price.
View analysts price targets for GLPG
or view top-rated stocks among Wall Street analysts.

How have GLPG shares performed in 2023?

Galapagos' stock was trading at $44.38 at the beginning of the year. Since then, GLPG shares have decreased by 2.4% and is now trading at $43.33.
View the best growth stocks for 2023 here
.

Are investors shorting Galapagos?

Galapagos saw a decrease in short interest during the month of January. As of January 15th, there was short interest totaling 1,010,000 shares, a decrease of 12.9% from the December 31st total of 1,160,000 shares. Based on an average daily volume of 174,300 shares, the short-interest ratio is currently 5.8 days.
View Galapagos' Short Interest
.

When is Galapagos' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, February 23rd 2023.
View our GLPG earnings forecast
.

What is Onno van de Stolpe's approval rating as Galapagos' CEO?

6 employees have rated Galapagos Chief Executive Officer Onno van de Stolpe on Glassdoor.com. Onno van de Stolpe has an approval rating of 100% among the company's employees. This puts Onno van de Stolpe in the top 10% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of Galapagos own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Galapagos investors own include Gilead Sciences (GILD), Celyad Oncology (CYAD), Intercept Pharmaceuticals (ICPT), NVIDIA (NVDA), argenx (ARGX), AbbVie (ABBV), Biogen (BIIB), Pharming Group (PHGUF), Trade Desk (TTD) and Collegium Pharmaceutical (COLL).

When did Galapagos IPO?

(GLPG) raised $161 million in an initial public offering (IPO) on Thursday, May 14th 2015. The company issued 3,800,000 shares at a price of $42.43 per share. Morgan Stanley, Credit Suisse and Cowen and Company acted as the underwriters for the IPO and Nomura and Bryan, Garnier were co-managers.

What is Galapagos' stock symbol?

Galapagos trades on the NASDAQ under the ticker symbol "GLPG."

Who are Galapagos' major shareholders?

Galapagos' stock is owned by a variety of institutional and retail investors. Top institutional shareholders include Monaco Asset Management SAM (0.03%), XR Securities LLC (0.00%) and Concourse Financial Group Securities Inc. (0.00%).

How do I buy shares of Galapagos?

Shares of GLPG stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Galapagos' stock price today?

One share of GLPG stock can currently be purchased for approximately $43.33.

How much money does Galapagos make?

Galapagos (NASDAQ:GLPG) has a market capitalization of $2.85 billion and generates $573.66 million in revenue each year.

How many employees does Galapagos have?

The company employs 1,309 workers across the globe.

How can I contact Galapagos?

Galapagos' mailing address is GEN DE WITTELAAN L11 A3, MECHELEN C9, 2800. The official website for the company is www.glpg.com. The biotechnology company can be reached via phone at (321) 534-2900, via email at ir@glpg.com, or via fax at 321-534-2901.

This page (NASDAQ:GLPG) was last updated on 2/3/2023 by MarketBeat.com Staff